Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab’
Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, Teresa Battista, Matteo Megna
Clinical and Experimental Dermatology · 2023-03
Abstract
This letter comments on ‘Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab’.
MeSH terms
- Hidradenitis suppurativa
- Medicine
- Adalimumab
- Psoriasis
- Dermatology
- Biosimilar
- Paradoxical reaction
- Tumor necrosis factor alpha